The Science of Fibroblasts
Experienced financial executive joins the executive team at Houston based company HOUSTON, June 2, 2022 /PRNewswire/ – FibroBiologics, a clinical-stage company focused on the development
HOUSTON, May 31, 2022 – FibroBiologics, a clinical-stage biotechnology company developing fibroblast-based therapeutic cures for chronic diseases, will present preclinical and safety-centered limited clinical trial
Expert in Infectious Disease Joins World-Renowned Scientists Advising Houston Company on Development of Fibroblast Cell-Based Therapeutics for a Wide Range of Chronic Diseases HOUSTON, March
